Post-Operative Analgesic Effect of Tramadol and Nalbuphine in Smoker and Non-Smoker Patients in LC

NCT07049380 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2025-07-03

No results posted yet for this study

Summary

This study aims to compare pain severity and analgesic requirements between smokers and nonsmokers following laparoscopic cholecystectomy, evaluating the efficacy of two analgesics, tramadol and nalbuphine.

Conditions

  • Laparocele

Interventions

DIAGNOSTIC_TEST

Comparative cross sectional

evaluating the efficacy of two analgesics, tramadol and nalbuphine. The primary objectives are to estimate pain severity in smokers versus nonsmokers and identify the effect of tramadol and nalbuphine between these groups

Sponsors & Collaborators

  • Superior University

    lead OTHER

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-17
Primary Completion
2025-08-01
Completion
2026-02-28

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07049380 on ClinicalTrials.gov